FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Talis Biomedical Corporation Stock AnalysisComprehensive stock analysis for Talis Biomedical Corporation (TLIS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTLIS
TLIS
Talis Biomedical Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TLIS
Home🔹Stocks🔹Talis Biomedical Corporation

Talis Biomedical Corporation

TLIS•OTC

Talis Biomedical Corporation

TLIS•OTC
Market cap
$5.18M
Sentiment

Your view on TLIS

Mkt Cap
$5.18M
Sentiment
Your view
TLIS
Talis Biomedical Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TLIS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Talis Biomedical Corporation

Industry
Medical - Devices
Sector
Healthcare
CEO
Rebecca Markovich
Headquarters
230 Constitution Drive, Menlo Park, CA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Rebecca Markovich
Headquarters
230 Constitution Drive, Menlo Park, CA, US
Description

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News